Publications by authors named "Tetsurou Inokuma"
Article Synopsis
- Nivolumab is the standard treatment in Japan for patients with advanced esophageal squamous cell carcinoma (ESCC) who can't tolerate traditional chemotherapy.
- A study analyzed clinical data of 93 patients treated with nivolumab to assess inflammatory prognostic factors like CAR (C-reactive protein/albumin ratio) and their impact on survival.
- Results showed that patients with a CAR value below 0.62 had significantly longer overall survival, indicating that CAR is a useful predictor of prognosis in these patients.
Here, we report the case of a 57-year-old Peruvian man on long-term corticosteroid therapy for a drug allergy and proton pump inhibitors for chronic dyspepsia symptoms. Upper gastrointestinal endoscopy showed multiple white granular lesions and widespread erosions in the stomach. Our findings indicate that gastric strongyloidiasis should be carefully considered in high-risk patients even if endoscopic findings are nonspecific.
View Article and Find Full Text PDFFour resected specimens of hepatic angiomyolipoma in which uptake of Sonazoid was observed in the postvascular phase of Sonazoid-enhanced ultrasonography were analyzed. Macrophage localization in the tumor was revealed pathologically by immunohistochemical staining for CD68. CD68-positive cells were observed in the tumor in all cases.
View Article and Find Full Text PDF